SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IRWIN JAMES FRANKEL who wrote (5011)8/13/2001 9:40:57 PM
From: Biomaven   of 10280
 
IJ,

Strange. I wonder if they have something other than Xopenex that they are including in product revenues.

From the 10Q:

Product revenues were $33,016,000 and $9,635,000 for the three months ended June 30, 2001 and 2000, respectively. The increase for the three month period ended June 30, 2001 is due primarily to increased sales of XOPENEX.

That "primarily" tends to imply that there is something else included there. (Or it could just be boilerplate.)

Probably not worth pursuing.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News